PMID: 9546032Apr 18, 1998Paper

Maple syrup urine disease: it has come a long way

The Journal of Pediatrics
D T Chuang

Abstract

Maple syrup urine disease (MSUD) was first described in 1954 by Menkes et al. as a progressive neurologic degenerative disorder. In 1960, Dancis et al. established that the metabolic block in MSUD is at the decarboxylation of branched-chain alpha-ketoacids derived from leucine, isoleucine, and valine. The multienzyme complex affected in MSUD, the mitrochondrial branched-chain alpha-ketoacid (BCKD) dehydrogenase complex was purified in 1978 to homogeneity in Reed's laboratory. This led to the later cloning of cDNAs and genes for subunits of the human BCKD complex. Genetic heterogeneity in MSUD is now explained by the various mutations that occur in the E1 alpha, E1 beta, E2, and E3 loci of the BCKD complex. Recently, we found that bacterial chaperonins GroEL and GroES promote folding and assembly of E1 decarboxylase component of the BCKD complex in Escherichia coli. Pulse-chase labeling in this system showed that a subset of E1 alpha mutations, notably the homozygous Y393N-alpha in Mennonite MSUD patients, impedes the assembly of the mutant E1 alpha subunit with normal E1 beta. The assembly defect is associated with a rapid degradation of the normal E1 beta subunit in MSUD cells. Retrovirus-mediated transduction of lymphoblasts ...Continue Reading

References

Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·F H PettitL J Reed
Feb 1, 1989·The Biochemical Journal·S J Yeaman
Jul 19, 1986·The Veterinary Record·P A HarperJ A Dennis
Feb 13, 1971·Lancet·C R ScriverE Delvin
Aug 1, 1972·The Journal of Pediatrics·J DancisR P Cox
Sep 23, 1960·Biochimica Et Biophysica Acta·J DANCISM LEVITZ

❮ Previous
Next ❯

Citations

Apr 8, 2006·Journal of Inherited Metabolic Disease·T I Ben-OmranA Feigenbaum
Aug 10, 2007·Antioxidants & Redox Signaling·Gary E Gibson, John P Blass
Feb 9, 2010·Genetic Testing and Molecular Biomarkers·Stephanie M CarletonCharlotte L Phillips
Nov 10, 2001·Annual Review of Genomics and Human Genetics·H L Levy, S Albers
Mar 16, 2011·International Journal of General Medicine·Marta DaniottiLuca Filippi
May 7, 2014·Journal of Inherited Metabolic Disease·Kim WagerClaire Russell
Oct 3, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·Y QuJ G Coldwell
Aug 2, 2011·Transplantation Reviews·William H Kitchens
Sep 1, 2005·Protein Science : a Publication of the Protein Society·Stephen W RasoDavid N Brems
Apr 17, 2015·Journal of Pediatric Endocrinology & Metabolism : JPEM·Wei Xia, Wenzhong Yang
Jun 27, 2013·Molecular Genetics and Metabolism·Heather A ZimmermanChristopher J Lynch
Feb 24, 2005·Micron : the International Research and Review Journal for Microscopy·James R Smith, J Alan Swift
Jun 13, 2006·Implant Dentistry·Dan OelgiesserDevorah Schwartz-Arad
May 24, 2015·Metabolic Brain Disease·Caroline Paula MesckaCarmen Regla Vargas
Jun 27, 2019·Scientific Reports·Alba-Aina CastellsÀngels Garcia-Cazorla
Feb 17, 2001·Muscle & Nerve·K A KleopaS J Bird
Mar 22, 2019·Reviews on Recent Clinical Trials·Francesco SantopaoloLeonardo Baiocchi
Mar 23, 2017·Journal of Inherited Metabolic Disease·Juliette BouchereauManuel Schiff
Jul 18, 2002·Journal of Inherited Metabolic Disease·A DursunI Ozalp
Jun 8, 2000·Journal of Natural Products·T R GarbeH Yukawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved